Le Lézard
Classified in: Health, Covid-19 virus
Subject: STP

National Pharmacy Group Commends Florida Gov. DeSantis on COVID-19 Testing Announcement


ARLINGTON, Va., April 24, 2020 /PRNewswire/ -- National Association of Chain Drug Stores (NACDS) President & CEO Steven C. Anderson, IOM, CAE, issued the following statement today:

"Throughout this crisis, Gov. DeSantis has been one of the true leaders across the nation in helping to remove barriers so pharmacies and pharmacists can help to meet people's health and wellness needs. Building off a recent effort to allow pharmacists to test and treat for flu and strep in Florida, the Governor took another important action today by directing the state's Surgeon General to allow licensed pharmacists to order and administer COVID-19 tests. This builds on an important guidance issued by the U.S. Department of Health and Human Services on April 8 to accelerate the availability of unencumbered testing across the nation. Ultimately, this action should allow pharmacies and pharmacists to effectively ramp up testing to ensure Floridians' health and to help re-open the state's vibrant economy."

Information about Floridians' opinions on COVID-19 issues related to pharmacy can be found here.

NACDS represents traditional drug stores, supermarkets and mass merchants with pharmacies. Chains operate nearly 40,000 pharmacies, and NACDS' 80 chain member companies include regional chains, with a minimum of four stores, and national companies. Chains employ nearly 3 million individuals, including 155,000 pharmacists. They fill over 3 billion prescriptions yearly, and help patients use medicines correctly and safely, while offering innovative services that improve patient health and healthcare affordability. NACDS members also include more than 900 supplier partners and over 70 international members representing 21 countries.

NACDS members operate more than 3,500 locations in Florida, with total employment of more than 224,000 people.

SOURCE National Association of Chain Drug Stores


These press releases may also interest you

at 23:33
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 21:00
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

at 19:30
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:51
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...



News published on and distributed by: